Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine

This publication has 15 references indexed in Scilit:

• Serum β₂-Microglobulin and Serum Thymidine Kinase are Independent Predictors of Progression-Free Survival in Chronic Lymphocytic Leukemia and Immunocytoma
  Leukemia & Lymphoma, 1996
• Risk Classification for Large Cell Lymphoma using Lactate Dehydrogenase, Beta-2 Microglobulin, and Thymidine Kinase
  Leukemia & Lymphoma, 1995
• Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications
  Annals of Hematology, 1992
• Serum thymidine kinase in monoclonal gammopathies. A prospective study
  Cancer, 1992
• A comparative study of proliferation‐associated parameters in b‐cell non‐hodgkin lymphoma
  Hematological Oncology, 1991
• Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group
  American Journal of Hematology, 1988
• Activity of serum thymidine kinase in non-Hodgkin lymphoma: Relationship to other prognostic factors
  Journal of Molecular Medicine, 1988
• Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia
  European Journal of Haematology, 1987
• Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia
  Cancer, 1984
• The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma
  British Journal of Cancer, 1983